— Know what they know.
Not Investment Advice

CLX

NYSE · USD
The Clorox Company
Consumer Defensive · Household & Personal Products
CEO Linda J. Rendle Employees 9,200 R&D / revenue 1.7%
Last price
$87.09+1.03%last session
Market cap
$10.5B
P/E (TTM)
18.1x
From 52w high
−32.4%
From 52w low
+10.1%
1-year return
−22.5%
RSI 14 · vs SMA200
53.5 · −12.1%
IS score
40.0/ 100
Factor model across 8 sub-scores, ranked against 3,010 US stocks. Describes the business, not the outlook.
Download full factsheet (PDF)

One year, rebased to 100

CLX   SPY   XLP (sector ETF) · weekly closes
708090100110120Jan 26Apr 26Jul 26Oct 26SPY 116XLP 111CLX 78

Score DNA

Each bar is a 0-100 score within the scored universe
68
Profitability
41
Growth
49
Value
45
Momentum
50
Risk (safety)
50
Quality
25
Balance sheet
82
Earnings quality

Flags

Strengths
✓ Insider buying
Warnings
None of the computed warning flags fires for CLX (Altman, Beneish, accruals, FCF, dilution).
Observations
Moat model: Weak, Cost AdvantagePiotroski 4 / 9Altman Z 2.1Beta 0.543 of 4 smart-money sources active

Smart-money strip

Each disclosure source on its own window. Filings coinciding is not coordination.
INSForm 4 · 180 days
Insider open-market buys
1
$0.43M bought
No Form 144 notices in 12 months
CONGSTOCK Act · 180 days
Congressional purchases
0
No disclosed purchases
Members disclose in ranges, 30-45 days after the trade
13F13F · quarter to 2026-06-30
Net change in institutional holders
−36
138 new holders, 159 closed
1,056 filers hold 86.5% · 406 added, 360 trimmed
ETFETF holdings · 30 days
Net funds accumulating
+119
602 funds adding shares
483 funds trimming · counts of funds, not dollars
DARKFINRA · daily
Short-sale share of off-exchange volume
51.2%
20-day avg 63.1%, 50-day avg 64.7%
Latest 11.9 pp under its 20-day average · a flow, not short interest

Key financials · FY2026

USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.
Income statement
Revenue$6.7B
Revenue growth YoY−5.4%
Gross margin42.3%
Operating income$1.7B
Operating margin24.7%
Net income$587.0M
Net margin8.7%
EPS (diluted)$4.81
Cash flow
Operating cash flow$612.0M
Capital expenditure$207.0M
Free cash flow$405.0M
FCF conversion (FCF / OCF)66.2%
Stock-based compensation$48.0M
FCF less SBC$357.0M
Buybacks$256.0M
Dividends$602.0M
Balance sheet & returns
Cash & short-term investments$143.0M
Total debt$5.1B
Net debt$4.9B
Shareholders' equity$252.0M
Goodwill & intangibles$2.6B
Debt / equity61.33
ROE (TTM)-1,893.5%
ROIC (TTM)20.4%
Operating margin by fiscal year
10.2%FY202211.6%FY202313.0%FY202416.7%FY202524.7%FY2026
Revenue $7.1B (FY2022) to $6.7B (FY2026), a -1.4% CAGR.

Valuation

P/E (TTM)18.1x
EV / EBITDA13.6x
Price / sales1.57x
Price / FCF26.0x
FCF yield3.85%
Buyback yield2.43%
SBC / revenue0.7%
Price / book117.84x
Forward P/E FY202715.2x
Forward P/E FY202814.2x
Forward multiples divide today's price by Street EPS estimates. Street mean target $93.40 across 10 analysts last quarter is theirs, not ours.

CLX vs industry median

112 companies in Household & Personal Products
Gross margin 42.3% 49.5% Operating margin 24.7% 4.8% Net margin 8.7% 0.4% ROIC 20.4% 10.5%
CLX (TTM)Industry median Asset turnover 0.86 vs industry 0.81 · financial leverage 86.60

Earnings delivery

Next report 2026-11-02 · consensus EPS $1.08
83%
beat rate, 10 of 12 quarters
+14.1%
median EPS surprise
6
longest beat streak
+345+100+26+17+32+12-6+30+4-3+6+1
EPS surprise in % vs the consensus at the time, oldest (left) to newest, 2023-11-01 to 2026-08-03. Bars cap at ±60%.

Peers

Market-cap band, not the industry cohort above
CompanyMkt capP/EROENet marginRev growth12m return
CLX The Clorox Company $10.5B18.1x-1,893.5%8.7%−5.4% −22.5%
ELF e.l.f. Beauty, Inc. $6.7B113.4x6.0%13.9%+31.2% −16.4%
REYN Reynolds Consumer Products I $4.8B13.9x15.5%9.4%+2.7% −2.0%
CHD Church & Dwight Co., Inc. $24.8B33.5x17.0%13.3%+2.7% +21.4%
IPAR Inter Parfums, Inc. $3.7B22.1x19.6%8.9%+2.9% +24.6%
KMB Kimberly-Clark Corporation $35.1B18.0x129.4%8.2%−12.3% —
KVUE Kenvue Inc. $36.3B21.7x15.6%11.5%+1.8% —
EL The Estée Lauder Companies $37.9B205.0x4.7%-3.2%+5.1% —
12-month window: SPY +15.9%, sector ETF XLP +11.4%. Past returns describe history only.

Recent 8-K filings

2026-08-03Earnings Release; Regulation FD; Exhibits
2026-06-17Officer/Director Change; Regulation FD; Exhibits
2026-05-28Officer/Director Change; Regulation FD; Exhibits
2026-04-30Earnings Release; Regulation FD; Exhibits
2026-04-01Regulation FD; Other Events; Exhibits
2026-03-10Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Statements and Exhibits

Context

Shares outstanding120,938,000
Free float99.4%
Institutional ownership86.5%
Beta0.54
Dividend yield5.71%
Last dividend$1.25 on 2026-10-28
50 / 200-day average$92.85 / $100.70
Large-cap Consumer Defensive median P/E23.3x

Full factsheet

The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Weak).

Read it in the browser Download (PDF)

All fundamentals · 140 measures in 13 categories

Percentile = where CLX sits among 20 scored companies in Household & Personal Products (0 = lowest value, 100 = highest). It is a position, not a grade.

Valuation

MeasureCLXIndustry medianIndustry percentileSector median
P/E (TTM) 17.9x 22.9x
9th
20.0x
PEG (P/E ÷ 3-yr EPS CAGR) 0.30 2.19
0th
1.14
Price / sales 1.6x 2.0x
37th
1.1x
Price / book 117.0x 3.8x
95th
2.5x
Price / tangible book —
Price / free cash flow 26.0x 17.2x
94th
14.7x
Price / operating cash flow 17.2x 10.6x
75th
9.4x
Enterprise value $15.9B $6.2B
68th
$5.1B
EV / sales 2.4x 2.2x
53rd
1.3x
EV / EBITDA 13.6x 16.2x
31st
12.3x
EV / EBIT 17.3x 25.5x
36th
16.5x
EV / free cash flow 39.3x 20.6x
88th
18.2x
Earnings yield 5.6% 1.0%
95th
3.9%
FCF yield 3.8% 5.0%
21st
6.5%
Operating cash flow yield 5.8% 6.7%
37th
10.4%
Graham number (per share) $8.93 $20.47
18th
$35.68

Profitability (TTM)

MeasureCLXIndustry medianIndustry percentileSector median
Gross margin 42.3% 48.8%
37th
34.4%
EBITDA margin 17.4% 11.0%
68th
10.7%
Operating margin 24.7% 9.4%
100th
7.6%
EBIT margin 13.7% 6.5%
68th
6.9%
Net margin 8.7% 2.5%
63rd
3.3%
NOPAT margin 18.8% 6.9%
100th
4.8%
FCF margin 6.0% 8.6%
37th
7.6%
Operating cash flow margin 9.1% 11.7%
32nd
11.1%
R&D / revenue 1.7% 0.0%
79th
0.0%
SG&A / revenue 15.9% 29.8%
11th
21.1%
Stock comp / revenue 0.7% 0.9%
39th
0.5%
Effective tax rate 24.0% 21.4%
68th
23.2%

Returns on capital

MeasureCLXIndustry medianIndustry percentileSector median
ROE (on average equity) 285.6% 4.9%
95th
10.4%
ROA 8.8% 1.9%
79th
4.9%
ROIC 23.1% 10.5%
79th
8.2%
ROCE 18.3% 6.2%
79th
9.1%
Return on tangible assets 13.8% 5.2%
79th
7.2%
Cash ROIC (OCF / invested capital) 11.2% 13.6%
29th
15.0%
Gross profitability (GP / assets) 36.5% 35.5%
53rd
32.4%
ROIC, 3-yr average 16.5% 7.8%
76th
6.4%
ROIC, 5-yr average 15.1% 8.1%
71st
7.8%
ROE, 5-yr average 228.1% 8.7%
100th
11.4%
Incremental ROIC 26.9% -27.2%
79th
12.8%

Growth

MeasureCLXIndustry medianIndustry percentileSector median
Revenue growth (TTM YoY) -5.4% 2.2%
21st
3.8%
Revenue growth (QoQ) 16.6% 6.5%
84th
4.3%
Revenue CAGR, 3 yr -3.1% 1.5%
22nd
3.8%
Revenue CAGR, 5 yr -1.8% 2.6%
27th
5.1%
Gross profit CAGR, 3 yr -0.7% 5.6%
17th
4.0%
Operating income CAGR, 3 yr 24.7% 3.6%
92nd
4.3%
Net income growth (TTM YoY) -27.5% 0.5%
30th
5.6%
Net income CAGR, 3 yr 57.9% 6.0%
100th
5.4%
EPS growth (TTM YoY) -26.6% 1.8%
30th
4.7%
EPS CAGR, 3 yr 59.0% 6.6%
100th
6.8%
EPS CAGR, 5 yr -3.2% -1.3%
33rd
4.1%
FCF growth (TTM YoY) -46.8% 24.1%
0th
23.4%
FCF CAGR, 3 yr -24.2% 6.5%
15th
14.6%
Operating cash flow CAGR, 3 yr -19.1% 5.2%
7th
6.4%
Book value CAGR, 3 yr -25.3% 2.6%
12th
5.3%
Dividend CAGR, 3 yr 0.7% 1.2%
33rd
1.7%
Sustainable growth rate -7.3% 7.2%
9th
8.3%

Margin history & stability

MeasureCLXIndustry medianIndustry percentileSector median
Gross margin, 3-yr average 43.4% 49.2%
37th
34.7%
Operating margin, 3-yr average 18.2% 8.6%
89th
6.7%
Net margin, 3-yr average 8.0% 5.1%
58th
4.2%
FCF margin, 3-yr average 7.8% 7.4%
58th
6.5%
Revenue stability (0-1) 0.72 0.71
53rd
0.81
Earnings stability (0-1) 0.01 0.39
11th
0.34
Margin stability (0-1) 0.95 0.95
42nd
0.95

Liquidity (latest quarter)

MeasureCLXIndustry medianIndustry percentileSector median
Cash & short-term investments $143.0M $243.9M
26th
$279.3M
Net cash (− = net debt) −$5.4B −$1.6B
26th
−$1.0B
Working capital −$949.0M $236.0M
5th
$285.9M
Current ratio 0.66 1.72
0th
1.43
Quick ratio 0.38 0.82
0th
0.86
Cash ratio (cash + ST investments / current liabilities) 0.05 0.34
5th
0.28
Defensive interval (days) 288 days 251 days
68th
251 days

Leverage & solvency (latest quarter)

MeasureCLXIndustry medianIndustry percentileSector median
Total debt $5.5B $1.8B
68th
$1.8B
Debt / equity 61.33 0.83
100th
0.75
Net debt / equity 59.74 0.69
100th
0.55
Debt / assets 70.8% 34.2%
100th
31.6%
Debt / capital 98.4% 45.2%
100th
43.0%
Debt / EBITDA 4.73 4.15
56th
2.69
Net debt / EBITDA 4.60 2.60
62nd
2.14
Interest coverage (EBIT / interest) 7.1x 2.8x
61st
4.7x
Cash interest coverage 4.7x 6.2x
39th
8.2x
Debt payback (years of OCF) 9.0 yrs 3.3 yrs
81st
2.8 yrs
Liabilities / assets 96.8% 59.0%
100th
56.2%
IS credit model rating BB — —
Implied credit spread (bps) 475 312
58th
225

Efficiency

MeasureCLXIndustry medianIndustry percentileSector median
Asset turnover 1.01 0.81
89th
0.94
Fixed asset turnover 3.51 6.92
22nd
4.44
Inventory turnover 6.0 3.6
89th
6.0
Receivables turnover 8.4 10.0
37th
12.1
Days sales outstanding 43 days 36 days
63rd
30 days
Days inventory outstanding 61 days 103 days
11th
61 days
Days payables outstanding 115 days 78 days
68th
38 days
Cash conversion cycle (days) −10 days 59 days
16th
37 days
Capex / revenue 3.1% 2.6%
71st
3.1%
Capex / depreciation 0.84 0.63
71st
0.92
Operating expense ratio —

Cash flow & earnings quality

MeasureCLXIndustry medianIndustry percentileSector median
Operating cash flow / net income 1.04 1.61
9th
1.87
FCF / net income 0.69 1.39
9th
1.28
FCF / operating cash flow 66.2% 78.2%
31st
71.9%
Capex / operating cash flow 33.8% 21.8%
69th
29.5%
Accruals ratio -0.4% -6.2%
95th
-6.1%
Sloan accruals ratio -13.3% -2.4%
5th
-3.9%
Earnings quality score (0-1) 1.00 0.75
73rd
0.75

Dividends & buybacks

MeasureCLXIndustry medianIndustry percentileSector median
Dividend yield 5.7% 1.7%
100th
1.8%
Dividend per share (TTM) $4.97 $0.76
95th
$0.64
Payout ratio (dividends / net income) 102.6% 58.4%
91st
32.1%
Dividends / FCF 148.6% 38.6%
100th
27.4%
Dividend growth (YoY) 1.3% 0.3%
54th
1.8%
Buyback yield 2.4% 0.9%
74th
0.9%
Shareholder yield (dividends + buybacks) 8.1% 3.6%
84th
3.6%
Share count change (YoY) -1.3% -0.1%
26th
-0.2%
Buybacks, last 5 years $1.6B $184.1M
84th
$184.1M

Scores & forensic checks

MeasureCLXIndustry medianIndustry percentileSector median
IS score 40 47
42nd
53
IS profitability 68 31
89th
32
IS growth 41 47
26th
50
IS value 49 46
63rd
49
IS momentum 45 62
21st
73
IS risk (safety) 50 65
32nd
80
IS quality 50 55
42nd
65
IS balance sheet 25 45
21st
53
IS earnings quality 82 66
89th
76
IS cash flow 34 59
21st
57
Piotroski F-score (0-9) 4 6
5th
6
Altman Z-score 2.1 2.8
32nd
3.2
Beneish M-score −2.01 −2.83
95th
−2.71
Ohlson O-score −4.71 −6.65
89th
−7.61
IS credit score 41 55
32nd
64

Per share

MeasureCLXIndustry medianIndustry percentileSector median
EPS, diluted (TTM) $4.81 $0.68
84th
$2.03
Book value per share $0.74 $8.09
5th
$16.28
Tangible book per share −$18.88 −$2.96
0th
$3.52
Revenue per share $55.02 $27.83
84th
$41.08
FCF per share $3.32 $3.23
53rd
$3.18
Operating cash flow per share $5.01 $4.84
63rd
$4.93
Cash per share $1.17 $3.22
37th
$2.81

Size (TTM)

MeasureCLXIndustry medianIndustry percentileSector median
Market cap $10.5B $3.3B
68th
$4.0B
Revenue $6.7B $3.5B
68th
$5.2B
EBITDA $1.2B $305.7M
68th
$426.9M
Net income $587.0M $69.7M
74th
$167.0M
Free cash flow $405.0M $285.9M
68th
$345.6M
Total assets $7.8B $4.5B
58th
$4.8B
Shareholders' equity $90.0M $1.3B
0th
$1.6B
Employees 9,200 6,350
63rd
9,700

Insider transactions, last 6 months

Form 4 · most recent 12
DateInsiderTypeSharesPriceValueOwned after
2026-10-05Rendle Linda J
Director, Chief Executive Officer
Award / grant 29,352$80.41$2.4M282,488
2026-10-05Rendle Linda J
Director, Chief Executive Officer
Tax withholding 692$80.41$55,644281,796
2026-10-05Rendle Linda J
Director, Chief Executive Officer
Tax withholding 11,989$80.41$964,035269,807
2026-10-05Peck Laurene E
VP - CAO & Corp Controller
Award / grant 1,172$80.41$94,24110,386
2026-10-05Peck Laurene E
VP - CAO & Corp Controller
Tax withholding 30$80.41$2,41210,356
2026-10-05Peck Laurene E
VP - CAO & Corp Controller
Tax withholding 339$80.41$27,25910,017
2026-10-05Marriner Kirsten
EVP - Chief Admin Officer
Award / grant 6,637$80.41$533,68183,591
2026-10-05Marriner Kirsten
EVP - Chief Admin Officer
Tax withholding 1,951$80.41$156,88081,640
2026-10-05Marriner Kirsten
EVP - Chief Admin Officer
Tax withholding 2,142$80.41$172,23879,498
2026-10-05Hyder Chris T
EVP-Chief Operating Officer
Award / grant 4,191$80.41$336,99894,618
2026-10-05Hyder Chris T
EVP-Chief Operating Officer
Tax withholding 100$80.41$8,04194,518
2026-10-05Hyder Chris T
EVP-Chief Operating Officer
Tax withholding 1,532$80.41$123,18892,986

Shares acquired vs disposed, by month

acquired disposed · all Form 4 types
MarAprMayJunJulAugSepOct

By transaction type, 6 months

TypeDirectionFilingsSharesValue
Award / grantAcquired37305,381$26.5M
Open-market buyAcquired15,000$429,124
Tax withholdingDisposed1528,097$2.3M
Awards, option exercises and tax withholding are compensation mechanics; open-market buys and sales are the discretionary ones.

Form 144 notices

FiledFilerShares proposedEst. proceeds
2025-09-04Eric Reynolds15,041$1.9M
2025-03-10Marriner Kirsten8,227$1.3M
2024-12-16Hilt Angela C1,248$205,820
2024-09-06Hilt Angela C1,733$285,980
A Form 144 is notice of a proposed sale, not a confirmed one.

Congress trades

12 months: House 13 trades (4 purchases) · Senate 0 (0 purchases)
TradedMemberChamberTypeAmountDisclosed
2026-05-15Gilbert CisnerosHouseSale$1,001 - $15,0002026-06-09
2026-05-15Gilbert CisnerosHouseSale (Full)$1,001 - $15,0002026-06-09
2026-05-14Gilbert Ray CisnerosHouseSale (Full)$1,001 - $15,0002026-06-09
2026-01-29Ro KhannaHouseSale$1,001 - $15,0002026-02-10
2024-04-29Tommy TubervilleSenatePurchase$1,001 - $15,0002024-05-15
2024-04-29Tommy TubervilleSenatePurchase$1,001 - $15,0002024-05-14
2024-04-29Thomas Hawley TubervilleSenatePurchase$1,001 - $15,0002024-05-14
2023-10-31Tommy TubervilleSenateSale (Partial)$100,001 - $250,0002023-11-16
STOCK Act disclosures, in ranges, filed up to 45 days after the trade.

Largest 13F holders

Quarter to 2026-06-30, the latest most managers have filed
ManagerSharesValue% of shares out
BlackRock, Inc.10,044,423$958.6M8.31%
STATE STREET CORP8,432,523$804.8M6.97%
VANGUARD CAPITAL MANAGEMENT LLC7,896,390$753.6M6.53%
Invesco Ltd.6,010,072$573.6M4.97%
VANGUARD PORTFOLIO MANAGEMENT LLC5,799,952$553.5M4.80%
GEODE CAPITAL MANAGEMENT, LLC3,265,551$310.4M2.70%
VAN ECK ASSOCIATES CORP2,972,952$283.7M2.46%
UBS Group AG1,978,411$188.8M1.64%
BANK OF AMERICA CORP /DE/1,883,700$179.8M1.56%
CITADEL ADVISORS LLC1,765,044$168.5M1.46%
ProShare Advisors LLC1,635,159$156.1M1.35%
Bank of New York Mellon Corp1,267,381$121.0M1.05%
CONFLUENCE INVESTMENT MANAGEMENT LLC1,247,644$119.1M1.03%
DIMENSIONAL FUND ADVISORS LP1,203,658$114.9M1.00%
NORTHERN TRUST CORP1,188,239$113.4M0.98%

Institutional ownership by quarter

2023-092026-0686.5%
% of shares held by 13F filers
2023-092026-061,056
Number of 13F filers holding

Holder changes by quarter

QuarterHoldersOwnershipNewIncreasedReducedClosed
2026-06-301,05686.5%138406360159
2026-03-311,09282.4%169410316111
2025-12-311,05581.8%162301437171
2025-09-301,09485.2%117376408135
2025-06-301,13089.6%103401427152
2025-03-311,19183.1%116421412135
2024-12-311,22782.5%17140539377
2024-09-301,15781.6%14534443572
2024-06-301,09683.5%97402386131
2024-03-311,15082.0%13637040283
2023-12-311,11281.3%15630245099
2023-09-301,06881.7%85385386147

Schedule 13D / 13G filers

FiledFormFiler% of classShares
2026-04-29SCHEDULE 13GVanguard Capital Management7.3%8,889,552
2026-03-26SCHEDULE 13G/AThe Vanguard Group0.0%0
2025-07-17SCHEDULE 13G/ABlackRock, Inc.8.1%9,954,343
2025-04-25SCHEDULE 13G/AUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC0.9%1,081,801
Required above 5% of a class; 13G is the passive form.

ETFs with the largest holding

ETFWeight in fundHolding value
VITSX0.01%$312.0M
VTI0.01%$312.0M
VTSAX0.01%$312.0M
VSMPX0.01%$312.0M
VFFSX0.01%$257.3M
VFIAX0.01%$257.3M

Share structure

Shares outstanding120,938,000
Float120,182,863
Free float99.4%

Income statement

Fiscal years, USD
FY2022FY2023FY2024FY2025FY2026
Revenue$7.1B$7.4B$7.1B$7.1B$6.7B
Cost of revenue$4.6B$4.5B$4.1B$3.9B$3.9B
Gross profit$2.5B$2.9B$3.0B$3.2B$2.8B
R&D$132.0M$138.0M$126.0M$121.0M$116.0M
SG&A$1.7B$1.9B$2.0B$1.9B$1.1B
Operating income$696.0M$827.0M$916.0M$1.2B$1.7B
EBITDA$928.0M$577.0M$736.0M$1.4B$1.2B
Pretax income$607.0M$238.0M$398.0M$1.1B$791.0M
Income tax$136.0M$77.0M$106.0M$254.0M$190.0M
Net income$462.0M$149.0M$280.0M$810.0M$587.0M
EPS, diluted$3.73$1.20$2.25$6.52$4.81
Diluted shares123.9M124.2M124.8M124.3M122.1M

Balance sheet

FY2022FY2023FY2024FY2025FY2026
Cash & short-term investments$183.0M$367.0M$202.0M$167.0M$143.0M
Receivables$681.0M$688.0M$695.0M$821.0M$791.0M
Inventory$755.0M$696.0M$637.0M$523.0M$777.0M
Total current assets$1.7B$1.8B$1.6B$1.6B$1.8B
PP&E, net$1.7B$1.7B$1.7B$1.6B$1.9B
Goodwill & intangibles$2.4B$2.0B$1.9B$1.8B$2.6B
Total assets$6.2B$5.9B$5.8B$5.6B$7.8B
Accounts payable$960.0M$1.0B$950.0M$838.0M$1.6B
Total current liabilities$1.8B$1.9B$1.6B$1.9B$2.8B
Long-term debt$2.5B$2.5B$2.5B$2.5B$4.0B
Total liabilities$5.4B$5.6B$5.3B$5.1B$7.5B
Shareholders' equity$729.0M$388.0M$492.0M$482.0M$252.0M

Cash flow statement

Outflows are negative
FY2022FY2023FY2024FY2025FY2026
Net income$471.0M$161.0M$292.0M$824.0M$601.0M
Depreciation & amortization$224.0M$236.0M$235.0M$219.0M$247.0M
Stock-based compensation$52.0M$73.0M$74.0M$81.0M$48.0M
Change in working capital−$99.0M$354.0M−$241.0M−$211.0M$118.0M
Operating cash flow$786.0M$1.2B$695.0M$981.0M$612.0M
Capital expenditure−$251.0M−$228.0M−$212.0M−$220.0M−$207.0M
Free cash flow$535.0M$930.0M$483.0M$761.0M$405.0M
Investing cash flow−$229.0M−$223.0M−$175.0M−$94.0M−$2.3B
Net debt issued / repaid−$83.0M−$188.0M−$45.0M$0$2.6B
Buybacks−$25.0M$0$0−$332.0M−$256.0M
Dividends paid−$571.0M−$583.0M−$595.0M−$602.0M−$602.0M

Ratio history

Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end
FY2022FY2023FY2024FY2025FY2026
Gross margin35.5%39.3%42.8%45.1%42.3%
Operating margin10.2%11.6%13.0%16.7%24.7%
Net margin6.5%2.0%3.9%11.4%8.7%
FCF margin7.5%12.6%6.8%10.7%6.0%
ROE95.6%38.4%102.2%249.6%285.6%
ROIC16.2%20.9%22.4%29.9%23.1%
ROA7.4%2.5%4.8%14.3%8.8%
Debt / equity5.5813.298.858.9761.33
Interest coverage7.3x3.3x4.9x12.0x7.1x
Current ratio0.970.951.030.840.66
Revenue growth−3.2%+4.0%−4.0%+0.2%−5.4%
EPS growth−34.1%−68.0%+87.3%+192.3%−26.6%
P/E at year end33.5x121.9x57.8x18.0x19.9x
EV / EBITDA at year end19.8x35.9x25.7x12.4x14.6x
FCF yield at year end3.45%5.12%2.98%5.23%3.47%
Dividend payout123.6%391.3%212.5%74.3%102.6%

Revenue by segment

FY2022FY2023FY2024FY2025FY2026
Health and Wellness$2.7B$2.5B$2.5B$2.7B$2.7B
Household$2.0B$2.1B$1.9B$2.0B$1.8B
Lifestyle$1.3B$1.3B$1.3B$1.3B$1.1B
International$1.2B$1.2B$1.2B$1.1B$1.1B

Revenue by region · FY2026

UNITED STATES$5.6B · 84%
Foreign$1.1B · 16%

Street estimates by fiscal year

Next report 2026-11-02 · consensus EPS $1.08 · these are analysts' numbers, not ours
Fiscal yearRevenue (mean)Revenue rangeEPS (mean)EPS rangeAnalystsP/E on mean EPS
2026$6.7B$6.7B – $6.7B$5.52$5.48 – $5.59915.8x
2027$7.6B$7.6B – $7.7B$5.72$5.50 – $5.781115.2x
2028$7.8B$7.7B – $7.9B$6.15$6.02 – $6.301014.2x

Reported vs expected, every quarter on file

ReportedEPS expectedEPS actualEPS surpriseRevenue expectedRevenue actualRevenue surprise
2026-08-03$1.64$1.66+1.2%$1.9B$1.9B+1.7%
2026-04-30$1.54$1.64+6.5%$1.7B$1.7B+0.0%
2026-02-03$1.43$1.39−2.8%$1.6B$1.7B+2.0%
2025-11-03$0.82$0.85+3.9%$1.4B$1.4B+2.1%
2025-07-31$2.20$2.87+30.5%$1.9B$2.0B+3.1%
2025-05-05$1.55$1.45−6.5%$1.7B$1.7B−2.7%
2025-02-03$1.39$1.55+11.5%$1.8B$1.7B−4.3%
2024-10-30$1.41$1.86+31.9%$1.6B$1.8B+6.9%
2024-08-01$1.56$1.82+16.7%$1.9B$1.9B−2.3%
2024-04-30$1.36$1.71+25.7%$1.9B$1.8B−3.0%
2024-02-01$1.08$2.16+100.0%$1.8B$2.0B+10.3%
2023-11-01$-0.20$0.49+345.0%$1.3B$1.4B+6.0%
2023-08-02$1.18$1.67+41.5%$1.9B$2.0B+7.6%
2023-05-02$1.20$1.51+25.8%$1.8B$1.9B+5.3%
2023-02-02$0.65$0.98+50.8%$1.7B$1.7B+3.4%
2022-11-01$0.73$0.93+27.4%$1.7B$1.7B+2.8%
2022-08-03$0.93$0.930.0%$1.9B$1.8B−3.4%
2022-05-02$0.97$1.31+35.1%$1.8B$1.8B+0.8%
2022-02-03$0.84$0.66−21.4%$1.7B$1.7B+1.4%
2021-11-01$1.03$1.21+17.5%$1.7B$1.8B+7.1%
2021-08-03$1.35$0.95−29.6%$1.8B$1.8B0.0%
2021-04-30$1.47$1.62+10.2%$1.9B$1.8B−4.4%
2021-02-04$1.78$2.03+14.0%$1.6B$1.8B+16.3%
2020-11-02$2.32$3.22+38.8%$1.8B$1.9B+8.9%

Off-exchange (dark pool) volume, weekly

FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)
0.306-150.306-220.206-290.307-060.407-130.207-200.307-270.508-030.408-100.408-170.308-240.408-31
Week ofNotionalSharesTrades
2026-08-31$385.6M4,013,73299,129
2026-08-24$258.1M2,457,69471,069
2026-08-17$383.9M3,598,17878,363
2026-08-10$411.5M3,865,22287,445
2026-08-03$506.5M4,944,852101,539
2026-07-27$330.3M3,370,37183,379

Short-sale share of off-exchange volume

daily 20-day average
07-2310-1551.2%
DateShort shareShort volumeTotal volume
2026-10-1551.2%760,4381,485,236
2026-10-1468.6%642,209935,527
2026-10-1367.1%575,829857,588
2026-10-1266.0%561,475850,638
2026-10-0963.2%429,280678,833
2026-10-0854.8%502,595916,774
2026-10-0770.8%665,669939,961
2026-10-0666.4%875,9821,319,816
2026-10-0565.8%797,2011,210,930
2026-10-0260.7%635,5171,047,420
A daily flow measure from FINRA, not short interest.

Seasonality

Average return by calendar month
+1.0Jan+0.1Feb+0.5Mar+0.6Apr-0.8May+0.5Jun+1.8Jul+1.1Aug-1.1Sep+1.0Oct+1.9Nov+0.1Dec
MonthAvg returnUp yearsYears
Jan+1.0%55%20
Feb+0.1%55%20
Mar+0.5%71%21
Apr+0.6%50%20
May−0.8%45%20
Jun+0.5%55%20
Jul+1.8%60%20
Aug+1.1%50%20
Sep−1.1%50%20
Oct+1.0%50%20
Nov+1.9%55%20
Dec+0.1%60%20
History, not a forecast.

Indicators

as of 2026-10-16
RSI 1453.5
MFI68.7
ADX32.2
Stochastic %K / %D89.8 / 86.3
Williams %R-6.8
CCI144
TSI / signal-15.6 / -27.4
Chaikin money flow0.07
ATR$2.16
Bollinger width9.5%
Volume vs 20-day avg1.01x
SupertrendDown

Moving averages and bands

level (price vs level)
SMA 20$83.43 (+4.4%)
SMA 50$92.40 (−5.7%)
SMA 200$99.09 (−12.1%)
EMA 21$85.21 (+2.2%)
EMA 50$89.10 (−2.3%)
EMA 200$98.11 (−11.2%)
Bollinger upper$87.39 (−0.3%)
Bollinger lower$79.48 (+9.6%)
Parabolic SAR$80.81 (+7.8%)
Open the live chart, 110+ indicators

About The Clorox Company

The Clorox Company is a global manufacturer and marketer of both consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division offers a range of cleaning solutions, including laundry additives and home care items under brand names such as Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409. It also supplies professional cleaning and disinfecting products via the CloroxPro and Clorox Healthcare brands, alongside professional food service goods from Hidden Valley. Additionally, this segment provides vitamins, minerals, and supplements (VMS) within the United States, marketed under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light labels. Dedicated to the U.S. market, the Household segment features cat litter products from Fresh Step and Scoop Away, food storage bags and wraps under the Glad brand, and grilling essentials like Kingsford charcoal. The Lifestyle segment, also primarily serving the U.S., encompasses dressings, dips, seasonings, and sauces, predominantly from Hidden Valley; natural personal care items offered by Burt's Bees; and water-filtration systems from Brita. Internationally, the International segment distributes a broad portfolio of products including laundry additives, home care items, water-filtration systems, digestive health products, grilling supplies, cat litter, various food items, bags and wraps, natural personal care products, and professional cleaning and disinfecting solutions. Key international brands include Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean, and Burt's Bees. Clorox's extensive product line reaches customers through a diverse array of channels. These include major retailers, grocery stores, warehouse clubs, discount outlets, home hardware centers, pharmacies, pet stores, military exchanges, both company-owned and third-party e-commerce platforms, distributors, and a direct sales force. Established in 1913, the company's corporate headquarters are situated in Oakland, California.

https://www.thecloroxcompany.com

Key executives

NameTitlePayBorn
Linda RendleChief Executive Officer & Chairman$3.3M1978
Nina BartonExecutive VP and Chief Growth & Strategy Officer$2.1M1974
Luc BelletExecutive Vice President & Chief Financial Officer$1.4M1979
Kirsten MarrinerExecutive Vice President & Chief Administrative Officer$1.3M1973
Chris T. HyderExecutive VP & COO$1.3M1975
Angela C. HiltExecutive Vice President, Chief Legal & External Affairs Officer and Corporate Secretary$1.3M1972
Erbie L. Foster Jr.Chief Diversity Officer——
Laura E. PeckVice President, Chief Accounting Officer & Corporate Controller—1977

Executive pay, latest proxy

ExecutiveYearSalaryStock awardsIncentiveTotal
Linda Rendle Chair and Chief Executive Officer (CEO)2026$1.3M$10.7M$1.2M$14.0M
Luc Bellet EVP and Chief Financial Officer (CFO)2026$751,923$6.3M$410,400$7.7M
Chris Hyder EVP and Chief Operating Officer2026$713,462$6.2M$390,457$7.6M
Kirsten Marriner EVP and Chief Administrative Officer2026$744,231$4.9M$364,500$6.2M
Angela Hilt EVP and Chief Legal & External Affairs Officer and Corporate Secretary2026$746,538$4.7M$344,250$6.0M

Employees

9k20199k20209k20219k20229k20238k20248k20259k2026

Dividends

Ex-dateAmountPaid
2026-10-28$1.252026-11-13
2026-08-12$1.252026-08-28
2026-04-22$1.242026-05-08
2026-01-28$1.242026-02-13
2025-10-22$1.242025-11-06
2025-08-13$1.242025-08-29
2025-04-23$1.222025-05-09
2025-01-29$1.222025-02-14

Moat model

Weak · Cost Advantage · 2026-06-30
Cost advantage76
Intangibles38
Switching costs26
Network effect27
Efficient scale75
Our component scores (0-100) and overall 46.5; a model of the business, not a call on the stock.
InsiderStreet reports findings from filings and market data. Nothing on this page is a recommendation to buy or sell.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms